Press Releases Immuron Limited

Equities

Market Closed - Australian S.E. Other stock markets 10:36:30 18/06/2024 am IST			5-day change	1st Jan Change
0.085 ^AUD	-4.49%		-3.41%	+10.39%

05/06	Immuron Limited Appoints Jeannette Joughin as Director	CI
31/05	Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	CI

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06	GL
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06	AQ
Immuron Board Changes	31/05	GL
Immuron CEO Steven Lydeamore to present at Peak Sky High	31/05	GL
Immuron Limited to Present at the Emerging Growth Conference	07/05	GL
Immuron Director Resignation	03/05	GL
Immuron Director Resignation	03/05	AQ
Immuron to host Live Virtual Event	15/04	GL
Immuron Travelan® sales continued strong growth	10/04	GL
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07/03	GL
Immuron Presentation Australian Biologics Festival 2024	21/02	GL
Immuron Presentation Australian Biologics Festival 2024	21/02	AQ
Immuron achieves record Travelan® sales	13/02	GL
Immuron achieves record Travelan® sales	13/02	AQ
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02	GL
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	08/02	AQ
Immuron achieves record half yearly Travelan® sales	16/01	GL
Immuron Clinical Trials Update	22/12	GL
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	04/12	GL
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	04/12	AQ

No results for this search